Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
22.16
-0.28 (-1.25%)
At close: Feb 13, 2026, 4:00 PM EST
22.54
+0.38 (1.71%)
After-hours: Feb 13, 2026, 7:38 PM EST

Immunome Revenue

Immunome had revenue of $9.68M in the twelve months ending September 30, 2025, down -4.44% year-over-year. In the year 2024, Immunome had annual revenue of $9.04M, down -35.50%.

Revenue (ttm)
$9.68M
Revenue Growth
-4.44%
P/S Ratio
181.62
Revenue / Employee
$57,613
Employees
168
Market Cap
2.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.04M-4.98M-35.50%
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition